SAN DIEGO — Aithanh Nguyen is skipping school to attend the American Society of Hematology’s annual meeting, but she has a legit excuse: On Monday, Nguyen was slated to take the podium here to present her research findings about a potential new mechanism for pain in sickle cell disease. The research could one day lead to new drugs to treat the chronic pain that plagues patients with the inherited blood disorder.

The missed classes are at a Connecticut boarding school, where Nguyen is a senior. She’s 17 and the youngest scientist making a presentation at the ASH annual meeting.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Aithanh, we are so proud of you. May God continue opening your heart and mind to reach out to our suffering sisters and brothers.

  • If every young “genius” would achieve just a fraction of what they are flaunted will achieve, there will be no more disease, wars and famine in the world.

    BTW, didn’t Global Blood Therapeutics and Bluebird Bio just made her research outdated? ………… So, mean

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy